Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

KITOV INSTITUTIONAL OWNERSHIP

Kitov Institutional Ownership estimation based on the recent filings.

https://www.sec.gov/Archives/edgar/data/1614744/000121390017004462/f20f2016_kitovpharma.htm

1. Goldman Hirsh Partners Ltd./Dr. Gil Pogozelich owns 11,292,508 ordinary shares (564.625 ADSs). Per TyrNovo deal, GHP accepted to be paid (half of the value) with Kitov's shares at around 3$;

2. JPW PCH LLC owns 2,184,431 ordinary shares (109.221 ADSs);

3. Dexcel Ltd owns 3,765,182 ordinary shares (188.259 ADSs). As per the agreement, the first issuance of 157,783 ordinary shares was made upon execution of the agreement, the second issuance of 597,511 ordinary shares was made upon attainment of the second milestone in May 2015, and the final issuance of 3,009,888 ordinary shares was made on June 19, 2016 in connection with the attainment of the fifth milestone;

4. Mr. Sheer Roichman / Haiku Capital Ltd. owns, as reported on the Schedules 13G filed on June 1, 2016 by Mr. Sheer Roichman and Haiku Capital Ltd., a company wholly-owned by Mr. Roichman, as of such date Haiku Capital beneficially owned 221,020 ordinary shares and held options issued by us to Haiku Capital representing the right to purchase 400,000 ordinary shares, and Mr. Sheer Roichman beneficially owned 2,473,780 ordinary shares (134.740 ADSs);

5. NEW INVESTORS (private placement) https://www.sec.gov/Archives/edgar/data/1614744/000121390017007408/f6k071117ex99i_kitovpharma.htm
Kitov issued 2,431,746 (ADSs) for some "mysterious" investors;

6. Ex-Tyrnovo investors https://www.sec.gov/Archives/edgar/data/1614744/000121390017010343/f6k100617ex99-1_kitovpharma.htm
Kitov issued 658,484 (ADSs) for ex-Tyrnovo investors;

7. Other Institutional Funds https://fintel.io/so/us/ktov
Insitutionals Funds filed 13-F for a total amount of 210,393 (ADSs);

That said, with a simplistic math, considering a total O/S of 11.316.716 (ADSs) we should have 38% of the float owned by Tutes/Investors:

1. GHP: 5%
2. JPW: 1%
3. Dexcel: 2%
4. Haiku/Roickman: 1%
5. New investors: 21%
6. Ex-Tyrnovo investors: 6%
7. Other Institutional funds: 2%

Interesting to note that both JPW (John Paul Waymack's fund), Dexcel and Haiku/Roichman (and recently GHP) has been severely diluted during these years. Interesting to note as well that GHP used to own 6.8% (now 5% after recent dilution) and it didn't have to report his stake in any form 13 to the SEC. That basically means that there could be other foreign funds owning some % in Kitov that we can not consider in this estimation.

Anyway, recent volume suggests that some Tutes entered as well increasing that percentage but this is just speculation considering we have to wait until they filed a 13-G or 13-F form filing or the 20-F filing from Kitov.